Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:05 AM
Ignite Modification Date:
2025-12-25 @ 12:05 AM
NCT ID:
NCT00797758
Eligibility Criteria:
Inclusion Criteria:
* Ages : 4 to 65
* De novo or secondary AML requiring allogeneic transplant
* No donor (related or unrelated) compatible 10/10
* Complete remission excepted CR1 with t(8;21) or inv (16) or t (15;17)
* Smouldering AML without progression
* Signed assent of recipient
Exclusion Criteria:
* If CR1: AML with with t(8;21) or inv (16) or t (15;17)
* Karnofsky \< 50% - Clearance of creatinin \< 40 ml/min
* Transaminases \> 8 N
* Previous autologous or allogeneic transplantation within 6 month prior to the study (except if tandem)
* total body irradiation contra-indicating 2 Gy TBI
* local irradiation contra-indicating 2 Gy TBI
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
4 Years
Maximum Age:
65 Years
Study:
NCT00797758
Study Brief:
Protocol Section:
NCT00797758